Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context

Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context

Background The R21/Matrix-M malaria vaccine has been shown to provide high protective efficacy against malaria in a phase III trial, and has been recommended for use by WHO. The vaccine will soon be deployed at scale in sub-Saharan Africa. This study aimed to understand the caregiver and community a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jayne Webster, Brian Greenwood, Daniel Chandramohan, Alassane Dicko, Issaka Sagara, Djibrilla Issiaka, Adrian VS Hill, Halimatou Diawara, Fatoumata Koita, Seydou Traoré, Jane Grant, Mehreen Datoo, Mala Sylla, Abdrahmane Boncane Dicko
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/10/2/e015524.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://gh.bmj.com/content/10/2/e015524.full

Similar Items